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Nephropathiccystinosis, a lysosomalstoragediseasecausedbymutations in theCTNSgeneencoding the lyso-
somal cystine transporter cystinosin, is characterizedbygeneralizedproximal tubule (PT) dysfunction that pro-
gresses, if untreated, to end-stage renal disease. The pathogenesis of defective PT cellular transport in
nephropathic cystinosis remains unclear. We characterized a recently generated line of C57BL/6 Ctnsmice
and analyzed endocytic uptake, lysosome function, and dedifferentiation and proliferation markers using pri-
mary cultures of PT epithelial cells derived from Ctns2/2 and Ctns1/1 littermates. Metabolic studies revealed
that Ctns2/2 mice show a progressive PT dysfunction characterized by low-molecular-weight (LMW) protein-
uria, glucosuria and phosphaturia, before structural damage and in the absence of renal failure. These changes
are related to decreased expression of themulti-ligand receptorsmegalin and cubilin and to increased dediffer-
entiation (ZONAB transcription factor) andproliferation (PCNAandCyclinD1) rates. Studies onPT cells derived
fromCtns2/2 kidneysconfirmedcystineoverload,withaccumulationof enlarged,dysfunctional lysosomesand
reduced expression of endocytic receptors reflected by decreased uptake of specific ligands. These changes
were related to a loss of integrity of tight junctions with a nuclear translocation of ZONAB and increased prolif-
eration, as observed in Ctns2/2 kidneys. These data reveal that the absence of cystinosin in PT cells triggers
aberrations of the endolysosomal compartment, transport defects and an abnormal transcription program in
theearly stageofnephropathiccystinosis. Insights into theearlymanifestationsof cystinosismayoffer new tar-
gets for intervention, before irreversible renal damage.
INTRODUCTION
The proximal tubules (PTs) of the kidney reabsorb the bulk of fil-
tered solutes and water, through polarized transport systems
which reflect terminal differentiation of epithelial cells. Global
dysfunction of these transport processes, which is referred to
as renal Fanconi syndrome, leads to the excessive urinary loss
of solutes (1). In turn, solute losses may cause dehydration and
electrolyte imbalance, rickets, muscular weakness, growth re-
tardation and progressive renal failure. Cystinosis is the most
frequent form of congenital renal Fanconi syndrome in children
(2). The disease is caused by autosomal recessive mutations in
the CTNS gene that encodes the lysosomal transporter cystinosin
(3,4). Loss of cystinosin function results in the accumulation of
cystine inside lysosomes and formation of cystine crystals in
multiple organs including the kidney. Nephropathic cystinosis
(NC), the most severe and frequent form of cystinosis, is charac-
terized by a progressive dysfunction of PT cells that appears by
6–12months of age. In the absence of treatmentwith cysteamine,
end-stage renal disease is reached around 10 years of age (2).
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The pathogenesis of defective PT transport in NC remains
unclear (5).Depletion of intracellularATP, abnormalities in cel-
lular glutathione levels affecting mitochondrial function and
redox state, increased apoptosis, as well as autophagy and
mitophagy, have been described in various model systems
(5–7). Although these events may coexist at various phases of
cell damage, their direct impact on the early defects in transport
causing renalFanconi syndrome isnot established.Similarly, the
involvement of themulti-ligand receptorsmegalin and cubilin in
the pathogenesis of cystinosis remains unclear. Studies on
humanbiopsymaterial revealed that the receptorswere normally
expressed in PT cells (8). Albumin uptake was not affected in
clonal cells derived from the urine of cystinotic patients (6), sug-
gesting that the mechanism of low-molecular-weight (LMW)
proteinuria may be different in NC than other types of PT dys-
function (5). Information on time course and relative importance
of tubular transport defects before onset of renal failure in NC is
also lacking, and the link between such defective transport pro-
cesses, residual cystinosin activity and lysosomal cystine accumu-
lation remains uncertain. Furthermore, treatmentwith cysteamine,
which depletes lysosomal cystine content, does not improve PT
dysfunction even when started early in life (2,9).
The difficulty to addressmechanisms of PTdysfunction inNC
is explainedat least inpartby limitationsof thecellular andanimal
models used thus far (5). Data obtained either on animal models
with incomplete phenotype, on non-renal or non-epithelial cell
types, or onclones of transformedcells isolated fromurine aredif-
ficult to analyze as these cell typesmay lack essential functions of
native PT cells. Renal biopsymaterial, usually obtained in case of
complications or at an advanced disease stage, is of limited value.
Until recently, nomousemodelmimicking the renal Fanconi syn-
drome and renal disease associated with cystinosis was available.
The first Ctns-null mouse model, obtained on a mixed 129/Sv ×
C57BL/6 genetic background, showed an accumulation of
cystine in the kidney and all organs tested, but failed to recapitu-
late the generalized PT dysfunction that is present in NC patients.
Recently, a congenicC57BL/6Ctns line showed accumulation of
cystin in the kidney,with signs of tubulopathy, severe histological
lesions and chronic renal failure from10 to 18months of age (10).
We have now used this Ctns mouse model to investigate the
mechanisms underlying specific transport defects in cystinosis,
based on in vivo, ex vivo and in vitromethods. Our results reveal
that the absence of cystinosin in PT cells triggers an early chain
of events leading to endolysosomal dysfunction, transport defects
and dedifferentiation appearing before structural damage and
renal failure.
RESULTS
Ctnsmice: progression of PT dysfunction
We first used the Ctns2/2 mice to characterize the time course
and progression of the renal phenotype before the onset of
renal failure (Fig. 1,Table 1).Whencomparedwithwild-type lit-
termates,Ctns2/2mice showed growth retardation and progres-
sivemanifestations of renal Fanconi syndrome, including LMW
proteinuria from the age of 12 weeks, followed by polyuria,
phosphaturia and glucosuria from 18 weeks. Generalized PT
dysfunction was observed at 24 weeks, with inappropriate loss
of megalin and cubilin ligands, including vitamin D-binding
protein (DBP), transferring (TF) and procathepsin B, in the
absence of renal failure (evidenced by similar levels of creatin-
ine clearance and BUN) (Fig. 1A and B; Table 1).
Typical features of nephropathic cystinosis were observed in
the Ctns2/2 kidneys at this stage: (i) focal atrophy of juxta-
glomerular PTs (‘swan neck’ lesions), restricted to 5% of
the nephrons whereas the renal parenchymawas looking strictly
normal (Fig. 1C); and (ii) lysosomal accumulation of cystine
crystals in PT cells, as shown by electronic microscopy
(Fig. 1C) and cystine assay in kidney cortex (Fig. 1D). As
expected, signs of renal failure were detected in Ctns mice
aged .30 weeks, with increased plasma levels of creatinine
and BUN (data no shown).
Abnormal expression of transporters and receptors
in Ctns2/2 kidneys
Having established the time course of renal Fanconi syndrome
in this model, we investigated the expression of transporters
and receptors in Ctns2/2 kidneys, focusing at 24 weeks of age
when PT dysfunction is observedwhile renal tissue is preserved.
These studies revealed that the urinary loss of solutes is asso-
ciatedwithdecreased expressionof specific transporters (includ-
ing NaPi-IIa and SGLT2) and receptors (megalin/cubilin) in
Ctns2/2 kidneys, at the mRNA and protein level (Fig. 2A–C).
The decreased expression was selective, as other components
of PT cells such as the water channel AQP1, the endocytic cata-
lyst Rab5a and the brush border component CD13 (aminopepti-
dase N) were unaffected (Fig. 2A and B). These data reveal that
the early phase of cystinosis is characterized by a specific trans-
port defect in vivo, caused by the loss of peculiar receptors and
transporters in PT cells.
Defective endocytosis and lysosomal function in PT cells
derived from Ctns2/2 kidneys
In order to confirm the cell specificity of the endocytic defect
observed in vivo, we developed primary cultures of PT cells
from microdissected PT segments of Ctns2/2 mice aged 20
weeks (Fig. 3). It has been shown previously that, when grown
on permeable supports, these primary cultured cells preserve
their differentiation and polarized transport processes (11). Our
functional studies showed that primary cultured PT cells obtained
from Ctns2/2 kidneys show defective endocytosis as evidenced
by an 70% reduction in albumin uptake when compared with
Ctns+/+ cells (23+5.0 versus 75+7.1 ng/mg protein.15 min,
n ¼ 5 pairs, P, 0.0005) (Fig. 3A and B). These changes were
associated with a decreased expression of megalin and cubilin
receptors, as well as of the apical transporters NaPi-IIa and
SGLT2 (Fig. 3C–E).
Since nephropathic cystinosis is characterized by lysosomal
dysfunction in vivo, we next investigatedwhether an impairment
of lysosomal function could be associated with defective endo-
cytosis in PT cells derived from 20-week-old Ctns mice. When
compared with Ctns+/+ control cells, the Ctns2/2 cells showed
a strong intracellular accumulation of cystine (Fig. 4A), as well
as the concentration of all lysosomal-related vesicles into fewer
and larger lysosomes that expressed late endosomal/lysosomal
markers lysosome-associated membrane protein 1 (LAMP1) or
LAMP2 (Fig. 4B). Similar results were obtained using cathepsin
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Figure 1.Ctnsmousemodel : progression of renal phenotype. (A) Growth retardation and evolution of PT dysfunction inCtns2/2mice. From 12weeks of age (blue
bars),Ctns2/2mice present a trend for lower bodyweight thanwild-type littermates, as well as increased urinary excretion of Clara cell protein (CC16), indicative of
LMWproteinuria in the absenceof renal failure (BUNandcreatinineclearance).At age18weeks (greenbars),Ctns2/2mice showsignificant growth retardation,with
an increased urinary excretion of glucose, phosphate and albumin. At 24 weeks of age (red bars), Ctns2/2 mice show a complete renal Fanconi syndrome, in the
absence of signs of renal failure. All values are expressed as percentage of wild-type, matched for age and gender (∗P , 0.05; ∗∗P , 0.01; ∗∗∗P, 0.001). Ten
pairs of Ctns mice were examined at each time point. (B) Urinary excretion of albumin (Alb, arrowhead), LMW proteins (LMWPs), vitamin D-binding protein
(DBP), TF and procathepsin B (CtsB) in 24-week-old Ctnsmice. Urine samples were loaded on 7.5% polyacrylamide gel electrophoresis, blotted to nitrocellulose
and incubatedwith appropriate primary antibodies. Loadingwas normalized to urinary creatinine concentration.Amajor increase in urinary excretion of albumin and
LMWP is detected in Ctns2/2 mice. (C) Structure of the Ctns kidneys. Upper and middle panels: staining with periodic acid Shiff and hematoxylin on Ctns kidney
sections obtained at 24 weeks of age. The Ctns2/2 kidneys show the typical swan neck lesions (arrows) in ,5% of nephrons. Otherwise, the renal parenchyma of
Ctns2/2 mice is normal. Lower panels: Electron microscopy of kidney cortex in 24-week-old Ctns2/2 mouse reveals lysosomal accumulation of cystine crystals
of various sizes in PT cells (arrows). Scale bar: 200 mm (top panels); 50 mm (middle panels); 5 mm (bottom left panel); 0.5 mm (bottom right panel). (D) Cystine
levels assay in kidney cortex from 24-week-old Ctns mice. A major increase in the cystine levels is observed in Ctns2/2 versus Ctns+/+ kidneys (57.3+2.8
versus 0.54+0.04 nmol 1/2 cystine/mg protein, n ¼ 4 pairs, ∗∗∗P , 0.001).
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Das a luminalmarker (Fig. 4B). Importantly, confocalmicroscopy
revealed that LAMP1-positive lysosomeswere dispersedwidely
throughout the cytosol in control cells, whereas lysosomes aggre-
gatedpredominantly in theperinuclear regionof cystinosin-depleted
cells (Fig. 4B).
Having shown that the loss of cystinosin function results in an
accumulation of enlarged lysosomes in PT cells, we next exam-
inedwhether the lysosomal enzymatic degradation capacity was
affected. Dynamic and quantitative analysis of lysosomal en-
zymatic activity was performed by monitoring the temporal re-
sponse of cathepsin B activity in live cells by fluorescence
Recovery After Photo-bleaching (FRAP) experiments. To this
end, living primary cultured PT cells from Ctns kidneys were
loaded with the membrane-permeable substrate, Magic Red
that, upon cathepsin B cleavage, releases fluorescent peptides
inside lysosomes. In control Ctns+/+ cells, photobleaching of
Magic Red-positive lysosomes was followed by a rapid (t1/2 ¼
47 s) and substantial (60%) recovery of the initial fluorescence
(Fig. 4F, upper panels). Conversely, in Ctns2/2 cells, the fluor-
escence recovery was slower (t1/2 ¼ 60 s) and smaller (20% re-
covery of the initial fluorescence) (Fig. 4F, lower panels). To
confirm the specificity of the Magic Red tracer, we incubated
Ctns+/+ cells with leupeptin so to block specifically the cathe-
psin B activity (Fig. 4G). The treatment with leupeptin sup-
pressed the release of fluorescent peptides, indicating that
Magic Red hydrolysis was cathepsin B dependent.
Dedifferentiation, proliferation and defective
transcriptional program in cystinosis
We next investigated potential mechanisms for the loss of PT
receptors and transporters expression in the early phase of
cystinosis. By analogy with other congenital or acquired disor-
ders of the PT, we reasoned that such changes could reflect a
dedifferentiated state of the epithelial cells due to a specific
transcriptional program (12,13). The 24-week-old Ctns2/2
kidneys showed amarked increase in the expression of the pro-
liferation markers PCNA and cyclin D1 (Fig. 5A and B). Both
molecules are classical targets of theY-box transcription factor
zonula occludens-1 (ZO-1)-associated nucleic acid-binding
(ZONAB) protein (14), which showed a nuclear translocation
(Fig. 5A) and co-enrichment with PCNA in nuclear extracts
ofCtns2/2kidneys (Fig. 5C). The fact that ZONAB drives pro-
liferation and directly repressesmegalin and cubilin in PT cells
(13) could explain the functional changes observed inCtns2/2
mice.
The latter hypothesis was substantiated in PT cells obtained
from Ctns mice (Fig. 6). The Ctns2/2 cells showed increased
proliferation (Fig. 6A), and a major nuclear translocation of
ZONAB together with PCNA expression (Fig. 6B and C).
Since the mRNA expression of ZONAB is unchanged in
these cells, we tested whether the increased ZONAB activity
could reflect a loss of tight junction integrity (14). The
primary cultured PT cells obtained from Ctns2/2 kidneys
showed a loss of tight junction integrity as evidenced by a
loss of signal for ZO1 (Fig. 6D and E) and a reduction in
the transepithelial resistance (Rt: 26.2+ 2.3 versus 58.4+
2.7 V/cm2) and current (Isc: 5.42+ 0.76 versus 14.2+
0.63 mA/cm2) compared with control cells (Fig. 6F).T
a
b
le
1
.
B
o
d
y
w
ei
g
h
t,
p
la
sm
a
an
d
u
ri
n
e
p
ar
am
et
er
s
in
th
e
C
tn
s
m
ic
e
B
o
d
y
w
ei
g
h
t
(g
)
U
ri
n
e
v
o
lu
m
e
(m
l/
2
4
h
)
G
F
R
(m
l/
m
in
/g
B
W
)
U
ri
n
ar
y
al
b
u
m
in
(m
M
/m
g
cr
ea
t/
d
l)
U
ri
n
ar
y
C
C
1
6
(m
g
/g
cr
ea
t)
U
ri
n
ar
y
C
al
ci
u
m
(m
g
/g
cr
ea
t)
U
ri
n
ar
y
p
h
o
sp
h
at
e
(m
g
/
g
cr
ea
t)
U
ri
n
ar
y
G
lu
co
se
(m
g
/g
cr
ea
t)
U
ri
n
ar
y
cr
ea
t
(m
g
/
d
l)
B
U
N
(m
g
/d
l)
P
la
sm
a
C
re
at
(m
g
/d
l)
C
tn
s+
/+
(n
¼
1
0
)
A
g
e
:
1
2
w
ee
k
s
2
1
.7
+
0
.8
8
9
1
+
1
0
5
5
1
+
9
2
7
4
6
+
4
6
8
1
6
+
6
1
3
+
2
6
5
+
8
1
.5
+
0
.0
8
5
6
+
4
3
6
+
1
0
.0
7
+
0
.0
0
4
C
tn
s2
/2
(n
¼
1
0
)
A
g
e
:
1
2
w
ee
k
s
1
9
.6
+
0
.4
∗∗
∗
9
4
6
+
1
1
7
5
0
+
4
3
0
8
7
+
1
1
9
1
1
7
+
3
7
∗∗
1
7
+
6
7
7
+
5
1
.5
+
0
.1
2
5
3
+
5
3
9
+
2
0
.0
8
+
0
.0
0
5
C
tn
s+
/+
(n
¼
1
0
)
A
g
e
:
1
8
w
ee
k
s
2
4
.5
+
0
6
8
4
7
+
1
2
5
5
0
+
5
2
5
4
7
+
2
5
7
1
3
+
4
1
2
+
4
6
4
+
6
1
.3
+
0
.0
3
5
7
+
3
3
8
+
5
0
.0
8
+
0
.0
0
1
C
tn
s2
/2
(n
¼
1
0
)
A
g
e
:
1
8
w
ee
k
s
2
0
.8
+
0
.2
∗∗
∗
9
3
5
+
1
0
9
5
1
+
2
3
1
5
7
+
2
8
7
∗∗
3
0
9
+
8
5
∗∗
∗
1
5
+
3
2
0
7
+
1
1
∗∗
∗
2
8
+
5
∗∗
∗
5
5
+
6
3
2
+
2
0
.0
8
+
0
.0
0
2
C
tn
s+
/+
(n
¼
1
0
)
A
g
e
:
2
4
w
ee
k
s
2
7
.5
+
0
.9
8
4
0
+
1
0
0
5
0
+
7
2
4
6
4
+
2
5
0
9
+
2
1
0
+
1
6
8
+
3
1
.4
+
0
.0
5
6
1
+
5
3
8
+
2
0
.0
8
+
0
.0
0
4
C
tn
s2
/2
(n
¼
1
0
)
A
g
e
:
2
4
w
ee
k
s
2
2
.6
+
0
.7
∗∗
1
5
7
0
+
1
0
5
∗
4
9
+
3
4
9
7
0
+
5
4
3
∗∗
∗
9
8
6
+
2
0
2
∗∗
∗
1
1
+
3
3
9
8
+
2
7
∗∗
∗
4
9
+
1
0
∗∗
∗
5
1
+
3
3
9
+
3
0
.0
8
+
0
.0
0
3
∗ P
,
0
.0
5
;
∗∗
P
,
0
.0
1
;
∗∗
∗ P
,
0
.0
0
1
Human Molecular Genetics, 2014, Vol. 23, No. 9 2269
DISCUSSION
In this study, we show that invalidation of cystinosin in mouse
induces a progressive dysfunction of the PTwith LMWprotein-
uria, glucosuria and phosphaturia, before structural damage and
in the absence of renal failure. These changes are related to aber-
rations in the endolysosomal compartment, with decreased ex-
pression of megalin and cubilin receptors and of specific
transporters, in parallelwith dedifferentiation and increased pro-
liferationofPTcells. Studies onprimary cultures ofPTcells con-
firmed both the defective endocytosis and the impaired
lysosomal function, with a loss of integrity of tight junctions
and an abnormal transcription program involving ZONAB.
These data reveal that, like other types of lysosomal storage dis-
orders, cystinosis is associated with aberrations affecting the
endolysosomal compartment (15,16).
In addition to glucose, amino acids, phosphate and other ions,
a significant amount of filtered albumin and LMW plasma pro-
teins is continuously reabsorbed by the epithelial cells lining
the PT. The uptake of LMW proteins by these cells essentially
involves receptor-mediated endocytosis, while fluid-phase
capture can be considered as quantitatively negligible. The
process essentially requires two multiligand receptors, megalin
and cubilin, and the cooperating protein amnionless that are
expressed at the brush border of the cells (17). Ligand binding
and interactions between both receptors induce their internaliza-
tion into coated vesicles and their subsequent delivery to endo-
somes and lysosomes for ligand processing and receptor
degradation or recycling. Over the past 15 years, the molecular
analysis of rare inherited diseases identified defective receptor-
mediated endocytosis as a major mechanism of renal Fanconi
syndrome (17–19). Selective proteinuria and manifestations of
Figure 2.Ctns kidneys: expression of endocytic markers. (A) Quantitative RT-PCR to measure the mRNA expression of PT genes (Aqp1, Lrp2, Cubn, Clcn5, Sglt2,
Sglt1, Slc34a1andAtp6v1e1)mRNAin24-week-old,wholeCtnskidneys (n ¼ 7pairs).AdecreasedexpressionofLrp2 (megalin),Cubn (cubilin),Sglt2 (SGLT2) and
Slc34a1 (NaPi-IIa)mRNAisobserved inCtns2/2 kidneysversusCtns+/+ controls (takenas100%,dotted line).ThemRNAexpressionof targetgeneswasnormalized
to the normalization factor calculated from four different housekeeping genes.Values are expressed asmean+SEM, ∗P , 0.05. (B) Representative immunoblotting
and densitometry analysis for PT markers megalin, cubilin, NaPi-IIa, AQP1, Rab5a and CD13 in 24-week-Ctns kidneys (n ¼ 4 pairs). Equal amounts of protein
extracts (20 mg) were run on SDS–PAGE, transferred to nitrocellulose and probed with appropriate antibodies. Membranes were stripped and reincubated for
b-actin. The expression of megalin, cubilin and NaPi-IIa is reduced in Ctns2/2 extracts, whereas the expression of AQP1, Rab5a and CD13 is unchanged versus
Ctns+/+. Densitometry values are expressed as mean+SEM, ∗P , 0.01; ∗∗P , 0.001; ∗∗∗P , 0.0001. (C) Immunofluorescence staining for megalin (a, b),
cubilin (c, d), NaPi-IIa (e, f) and AQP1 (g, h) in Ctns+/+ (a, c, e, g) and Ctns2/2 (b, d, f, h) kidneys from 24-week-old mice. The signal for megalin, cubilin and
NaPi-IIa is strongly reduced in the PT of Ctns2/2 kidneys, whereas staining for AQP1 is unchanged. Scale bar: 50 mm.
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PT dysfunction are detected in patients and corresponding
mouse models with inactivating mutations in LRP2 coding for
megalin (Donnai–Barrow syndrome) (20), in CUBN coding
for cubilin orAMN coding for amnionless (Imerslund–Gra¨sbeck
syndrome) (21), and the CLCN5 gene coding for the endosomal
exchanger ClC-5 (Dent’s disease) (19). Despite evidence of PT
dysfunction and renal Fanconi syndrome, the potential involve-
ment of megalin and cubilin in the pathogenesis of nephropathic
cystinosis has been questioned (5), relying on expression studies
in renal biopsies (8) and clonal cells derived from the urine (6).
Based on several lines of evidence, our studies demonstrate
that receptor-mediated endocytosis is involved in the PT dys-
function associated with cystinosis. Detailed metabolic studies
performed every 4 weeks allowed us to establish the time course
of tubulardysfunction inCtns2/2mice.Thesemiceshowprogres-
sivemanifestations of renal Fanconi syndrome (LMWproteinuria
including albumin and specific ligands of megalin and cubilin,
phosphate and glucose) from 12 weeks to 20 weeks, in the
absence of renal failure or major histology lesions. The fact that
,5% of nephrons show swan-neck lesions in the S1 segment at
this stage indicate that the urinary loss of solutes is not caused by
a loss of tubular functional mass, but rather by a specific mechan-
ism in apparently intact cells. The nature of this mechanism was
further investigated by using well-established primary cultures
of PT cells obtained from Ctns2/2 kidneys. When grown on
filters, these cells polarize and keep their differentiation as
shown by morphological features and specific transport processes
(11). Theprimary cultures are obtained fromdefinedPT segments,
at very precise stages of disease and with matched control cells
from littermates. The primary cells are particularly well-suited
to investigate receptor-mediated endocytosis and lysosomal
processing, as recently shown in mice KO for megalin (12) and
ClC-5 (22), twomodels that are directly relevant for nephropathic
cystinosis.
Analyses of PT cells obtained from Ctns2/2 kidneys reveal
that their functional defect includes both defective endocytosis
and impaired lysosomal processing. These changes are caused
by a selective decrease in the expression of megalin and cubilin
as well as cystine accumulation leading to enlarged, perinuclear
lysosomes. The lysosomal defect is evidenced by the strong de-
crease in cathepsinB activity revealed by FRAP analysis. Import-
antly, the PT phenotype of theCtns2/2 mice includes the urinary
loss of cathepsin B, as was already observed for the Clcn52/2
mice that mimic Dent’s disease (23). Of note, these defects do
not involve endosome catalysts (Rab5a) and components of the
brush border membrane (CD13), nor the lysosome-associated
Figure3.Defective endocytosis in PTcells fromCtns2/2 kidneys. (A)Confluentmonolayers of primary cultures of PTcells obtained from20-week-oldCtnskidneys
were incubated with 0.5 mg/ml Alexa488-conjugated BSA for 1 h at 48C, followed by 15 min incubation with growth medium at 378C. A decreased uptake of
Alexa488-BSA is observed inCtns2/2 cells comparedwith control cells (left panel; scale bar: 10 mm). The uptake ofAlexa488-BSAwas quantified in a single-beam
fluorimeter (right panel), confirming the major decrease in PT cells fromCtns2/2 versusCtns+/+ (23.5+5.0 versus 74.7+7.2 ng/mg protein.15 min, respectively,
∗∗P, 0.01). (B) QuantitativeRT-PCR to assess the expression of PTmarkers in primary cultures of PT cells obtained from20-week-oldCtns2/2 kidneys (compared
with levels inCtns+/+ cells taken as 100%). ThemRNAexpression of target geneswas normalized toGapdh. TheCtns2/2 cells show a decreased expression ofLrp2,
Slc34a1,Cubn, Sglt2mRNAversusCtns+/+ cells.Values are expressed asmean+SEM, ∗P , 0.05 (n ¼ 6 pairs). (C) Immunoblotting anddensitometry analysis for
megalin, cubilin and NaPi-IIa in primary cultures of PT cells fromCtns+/+ versusCtns2/2 kidneys. Equal amounts of proteins (15 mg) from cell cultures (six wells/
sample) were loaded on each lane. The expression of megalin, cubilin and NaPi-IIa is decreased in Ctns2/2 cells compared with wild-type. Values are expressed as
mean+SEM,n ¼ 5pairsof samples, ∗∗P , 0.01; ∗∗∗P , 0.001. (D)Monolayers ofPTcells fromCtns+/+ andCtns2/2 kidneyswere labeledwith antibodies against
megalin (green, left panel) and against cubulin (red, right panel). Confocalmicroscopy images (upper panels) andX–Z side viewof a z-stack (bottompanels) reveal a
decreased expression of megalin and cubulin at the apical plasma membrane in Ctns2/2 PT cells compared with wild-type cells. Nuclei counterstained with DAPI
(blue). Scale bar, 10 mm.
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Figure 4. Lysosomal dynamic and degradative capacity are altered in PT cells from Ctns2/2 kidneys. (A) Intracellular cystine assay in primary culture of PT cells
isolated from 20-week-old Ctns kidneys (N ¼ 6 samples). A major increase in intracellular cystine levels is observed in Ctns2/2 cells versus controls (78.7+13.9
versus5.1+1.4 nmol 1/2 cystine/mgprotein, respectively,n ¼ 4pairs of samples, ∗∗∗P , 0.001). (B) Primary culturedPTcells fromCtnskidneyswere labeledwith
antibodies against plasmamembrane and lysosomemarkers in order to evaluate the steady-state distribution of LAMP1, LAMP2 and cathepsin D (CtsD). Represen-
tative imagesofCtns2/2 PTcells showasignificant decrease in thenumberand an increase in the sizeofLAMP1-,LAMP2-andCtsD-positivevesicles, in comparison
withCtns+/+ cells. Nuclei counterstainedwithDAPI (blue). Scale bar, 10 mm.C-E. The cells from (B) were assessed in a blind fashion for (C) change in number and
size of LAMP1, LAMP2 and CtsD-positive vesicles, for (D) presence of enlarged lysosomes; and for (E) change in vesicle positioning. Values are expressed as
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proteins LAMP1 and LAMP2 (data not shown). The endocytic
defect in nephropathic cystinosis is thus very similar to that
encountered in Dent’s disease (24), indicating that the functional
loss of an endosomal chloride–proton exchanger (ClC-5) or of a
lysosomal transporter (cystinosin) may have the same functional
consequences on the endolysosomal compartment in PT cells.
In addition to receptor-mediated endocytosis, a second dis-
tinct pathway operating at the apical border of PT cells appears
to be defective in this cystinosis model. Indeed, Ctns2/2 mice
show phosphaturia and a decreased expression of NaPi-IIa
cotransporter in PT cells. It must be noted that LMWproteinuria
occurs at least 4weeks before phosphaturia in theCtns2/2mice.
Since phosphate reabsorption viaNaPi-IIa is under the control of
the parathyroid hormone (PTH) via its receptors (PTHR) located
on the apical and basolateral poles of the cells, one can hypothe-
size that a trafficking defect similar to that observed inClcn52/2
kidneys ex vivo (23) and in vivo (25) may be involved.
Our previous studies have shown that transcription factors play
an important role in the phenotypic changes observed inPTcells in
various types of renal Fanconi syndromes (13,14,26). Inparticular,
the Y-box transcription factor (ZONAB) protein promotes cell
proliferation (by inducing the expression of the proliferating
factors PCNA and cyclin D1) but directly represses megalin/
cubilin expression in PT cells (14). Our data show that the
mRNA expression of megalin/cubulin is decreased in Ctns2/2
kidneysandprimaryculturedcells,whereas thenuclear expression
ofZONABis increased.Furthermore,PCNAandcyclinD1,which
are direct targets ofZONAB, are also increased. TheCtns2/2 cells
are consistently hyperproliferative, whereas additional markers of
dedifferentiation are strongly increased. These data suggest that
the loss of cystinosin is associatedwith a switch between differen-
tiation and proliferation, which may involve a specific transcrip-
tional cascade in PT cells. Dedifferentiation would be reflected
by decreased expression of megalin/cubilin, causing defective
endocytosis and LMW proteinuria. Alternatively, the switch
towards proliferation could involve the loss of lysosomal function.
It is known that retention inside the endolysosomal compartment
with subsequent prolonged activation of the EGF-receptor may
cause dedifferentiation in renal PT cells (27). Future studies
using amulti-level approachbasedon transcriptomics, proteomics
andmetabolomics will be necessary to understand how the dysre-
gulated transcriptional program induced by the functional loss of
cystinosin may have an impact on key proteins involved in the
functions of PT cells.
In summary, our data reveal that the loss of cystinosin
function in PT cells triggers an abnormal transcription
program with profound defects in the endolysosomal pathway
leading to the urinary loss of specific ligands, before structural
damage or renal failure. Insights into the early manifestations
of nephropathic cystinosis may offer new targets for interven-
tion, before irreversible renal damage.
MATERIALS ANDMETHODS
Transgenic mice
All experiments were conducted on age- and gender-matched
Ctns+/+ and Ctns2/2 littermates (C57BL/6 background) (10).
The mice had free access to appropriate standard diet (Carfil
Quality, Oud-Turnhout, Belgium). All procedures were per-
formed in accordance with National Institutes of Health guide-
lines for the care and use of laboratory animals and with the
approval of the Committee for Animal Rights of the UCL
Medical School (Brussels, Belgium) and the University of
Zurich (Zurich, Switzerland).
Renal function parameters
After genotyping at 6 weeks, mice were trained and kept once
weekly in metabolic cages (overnight) with ad libitum access
to food and drinking water. The urine was collected over ice
and diuresis was measured. Blood (intracardiac puncture) and
kidneys were obtained after anesthesia with ketamine/xylazine
or isoflurane (23,24). The urine and blood parameters weremea-
suredusingaSynchronCX5analyzer (BeckmanCoulter,Fullerton,
CA, USA), whereas Clara cell protein (CC16) concentration was
measured in duplicate by latex immunoassay (courtesy of
X. Dumont, UCL Medical School, Brussels, Belgium). Urinary
LMWproteins, includingvitaminD-bindingproteinandtransferrin
(TF) were measured by western blotting as described previously
(23,24,28,29).
Histological studies
Kidneys from the Ctns mice were rapidly dissected, rinsed in
ice-cold PBS, fixed in 4% paraformaldehyde in 0.1 M phosphate
buffer for 6 h, and embedded in paraffin. Sections were deparaf-
finized with xylene and rehydrated with descending ethanol into
PBS, then stained with hematoxylin and eosin analyzed and
photographed with an Axioplan2 microscope (Carl Zeiss, Zaven-
tem,Belgium)andanAxioCamcamera (CarlZeiss).Sectionswere
read by a renal pathologist blinded to the animal group. For ultra-
structural examination, kidney sampleswere fixedwith 4%glutar-
aldehyde in PBS at 48C for 2 h. After washing with 0.1 M PBS,
samples were post-fixed with 1% osmium tetroxide, dehydrated
and embedded in araldite. Ultrathin sections were examined with
a JEOL 1010 transmission electron microscope (JEOL, Tokyo,
Japan) after uranyl acetate and lead citrate staining.
mean+SEM (n ¼ 50 cells; three independent experiments; ∗∗∗P , 0.001 (number) and ∗∗P , 0.01 (size); ∗∗∗P , 0.001 (enlarged lysosomes) and ∗∗P, 0.01
(positioning)). (F) FRAP assay of cathepsin B activity. Time-lapse of photo-bleaching and fluorescence recovery of Magic Red-positive lysosomes in primary PT
cells from Ctns +/+(upper panels) and Ctns2/2 (lower panels) cells. Representative images, with time intervals indicated in seconds. Right panel: FRAP analysis
of Magic Red- positive lysosomes from Ctns 2/2 and Ctns+/+ PT cells. The FRAP data are displayed as percentage of recovery with respect to the fluorescence
before bleach(100%) and are representative of 10 recordings from different cells. The fluorescence recovery is significantly attenuated inCtns2/2 cells as compared
with controlCtns+/+ cells (t1/2, time for exchanging half of the mobile Magic Red fraction between bleached and unbleached areas: 68+3.5 versus 47+2.9 s, re-
spectively,P , 0.05). (G)Validation of theMagicRed-cathepsinBassay.Representative image of treatmentwith 100 mM leupeptin [in dimethyl sulfoxide (DMSO)]
onCtns+/+ PT cells exposed toMagic Red-cathepsin B: a decreased degradation capacity of lysosomes is observed inCtns+/+ cells exposed to leupeptin compared
with DMSO alone. Scale bar, 10 mm. Right panel: quantification of cell-associated Magic Red vesicles, evaluated as mean fluorescence intensities per cell and
expressed in arbitrary units (a.u.; n ¼ 50 cells; three independent experiments, ∗∗P, 0.001).
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Antibodies
The following antibodies were used in this study: mouse
anti-rat PCNA (Dako, Glostrup, Denmark), rabbit anti-
human DBP (Dako), rabbit anti-human LMW proteins
(Dako), rabbit anti-human CC16 (BioVendor, Heidelberg,
Germany), rabbit anti-humanTF (Dako); goat anti-mouse cathe-
psin B/D (R&D, Minneapolis, USA); mouse anti- b-actin
(Sigma, St. Louis, USA); rabbit anti-human ZO1 (Invitrogen,
Life Technologies, Zug, Switzerland); rabbit anti-mouse and
anti-human ZONAB (Invitrogen; Bethyl Lab, Montgomery,
USA), rabbit anti-human AQP1 (Millipore, Billerica, USA),
rabbit anti-human CD13 (Abcam, Cambridge, UK), mouse anti-
human nuclear matrix protein p84 (Abcam), rabbit anti-NaPi-IIa
(gift from C. A.Wagner, University of Zurich, Zurich), rabbit anti-
mouse Rab5a (Sigma), rabbit anti-rat LAMP1 (Abcam), rabbit
anti-rat LAMP2 (Abcam). Sheep anti-megalin and rabbit
anti-cubilin were kindly provided by Dr. P. Verroust, INSERM,
Paris, France.
Isolation and primary cultures of PT cells
Primary cultures of mouse PT cells were prepared from gender-
matched Ctns+/+ and Ctns2/2 mice aged of 20 weeks as
described previously (11). For the isolation of PT cells, PT seg-
mentswere seeded onto collagen-coated PTFEfiltermembranes
(0.33 cm2, pore size 0.4 mm, Transwell-COLTM, CostarTM,
Corning Inc., USA) in culture medium (DMEM:F12 with
15 mM HEPES, 0.55 mM Na-pyruvate, 0.1 ml/l non-essential
amino acids and the SingleQuotsw kit (Lonza, Verviers,
Belgium) containing hydrocortisone, hEGF, FBS, epinephrine,
insulin, triiodothyronine, TF, gentamicin/amphotericin, pH
7.40, 325 mOsm/kg) and incubated in a humidified chamber at
378C–5%CO2.Themediumwas replaced every48 h.Confluent
monolayers of PT cells expanded from the tubular fragments
after 6–7 days. All experiments were performed on non-
passaged, confluent monolayers grown on collagen-coated
filters.
Quantitative real-time PCR
Total RNA was extracted from kidneys using AurumTM Total
RNAFatty and Fibrous TissueKit (Bio-Rad,Hercules, CA), fol-
lowing themanufacturer’s protocol. DNAse I treatmentwas per-
formed to eliminate genomic DNA contamination. Total RNA
was extracted from primary cell cultures with RNAqueousR
kit (Applied Biosystems, Life Technologies), following the
manufacturer’s protocol. One microgram of RNA was used to
perform the reverse transcriptase reaction with iScriptTM
cDNA Synthesis Kit (Bio-Rad). The primers were designed
using Beacon Designer 2.0 (Premier Biosoft International,
Palo Alto, USA) (Table 2). Changes in target genes mRNA
levels were determined by quantitative reverse transcriptase-
polymerase chain reaction (RT-PCR) with an iCycler IQ
System (Bio-Rad) using SYBR Green I detection of single PCR
product accumulation. The qRT-PCR analyses were performed
in duplicate with 100 nM of both sense and anti-sense primers in
a final volume of 20 ml using iQTM SYBR Green Supermix
Figure 5. Ctns2/2 kidneys: dedifferentiation and proliferation. (A) Quantitative RT-PCR analysis of the expression of the proliferation markers Pcna (PCNA) and
Ccnd1 (CyclinD1) and the transcription factorsNrf2 (NRF2) andDbpA (ZONAB)mRNA inwhole kidneys, obtained from24-week-oldCtnsmice (n ¼ 7 pairs). The
Ctns2/2 kidneys showan increased expression of PCNA,CyclinD1, andNRF2 in comparisonwithCtns+/+ samples (∗P , 0.05). (B)Upper panels:Double immuno-
fluorescence staining for PCNA and AQP1 in 24-week-old Ctns kidneys. An increased nuclear expression of PCNA is observed in the AQP1-positive PT cells of
Ctns2/2 kidneys, demonstrating an increased cellular proliferation.Lower panels: Immunofluorescence forZONABandAQP1 in 24-week-oldCtnskidneys. In com-
parison with wild-type tissue,Ctns2/2 kidneys show a nuclear concentration of ZONAB in AQP1-positive PT cells. G, glomeruli (AQP1 in erythrocytes). Scale bar
50 mm. (C) Representative immunoblotting of nuclear extracts from 24-week-old Ctns kidneys showing increased expression of ZONAB and PCNA in nuclei from
Ctns2/2 kidneys. Loading control was performed aftermembrane stripping and incubationwithmonoclonal antibody against nuclear matrix protein p84. Values are
expressed as mean+SEM on four pairs of samples. (∗P, 0.05; ∗∗P , 0.01).
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(Bio-Rad). PCR conditions were 948C for 3 min followed by 40
cycles of 30 s at 958C,30 s at 618Cand1 minat728C.The relative
changes in target gene/GAPDHmRNA ratio were determined by
the relation 22DDCt (30).
Western blotting
Protocol used for immunoblottinghas been described previously
(28,29). Proteins were extracted from isolated kidneys or
Figure 6. Proliferation and dedifferentiation in PT cells fromCtns2/2 kidneys. (A) Time-course of BrdU incorporation in primary cultures of PT cells obtained from
Ctns kidneys. Increased cell proliferation was detected in Ctns2/2 versus wild-type cells at each time point. Values are expressed as mean+SEM, n ¼ 4 pairs of
samples. ∗P , 0.05, ∗∗P , 0.01, ∗∗∗P , 0.001. (B) Immunofluorescence for ZONAB in primary cultures of PT cells fromCtns kidneys. Left panels: Representative
images showingnuclear translocationofZONABinCtns2/2 cells compared todiffuse cytoplasmic staining inCtns+/+ cells.Nuclei counterstainedwithDAPI (blue).
Scale bar, 10 mm. Right panels: Quantification of the number of cells with nuclear ZONAB. (n ¼ 50 cells; three independent experiments, ∗∗∗P, 0.001). (C) Im-
munoblotting and quantification for ZONABandPCNA in primary culturedPT cells obtained fromCtns+/+ andCtns2/2 kidneys. Equal amounts of proteins (15 mg)
from nuclear extracts (six wells/sample) were loaded in each lane. The expression of ZONAB and PCNA is increased inCtns2/2 cells, comparedwithCtns+/+ cells.
Values are expressed as mean+SEM, ∗P , 0.05; ∗∗P, 0.01. (D) Immunofluorescence for the tight junction protein ZO1 in primary cultures of PT cells obtained
from Ctns kidneys. Left panels: The steady-state distribution of ZO1 is altered in Ctns2/2 versus wild-type Ctns+/+ cells. Nuclei counterstained with DAPI (blue).
Scale bar, 10 mm. Right panel: Quantification of cell-associated ZO1, evaluated as mean fluorescence intensity per cell and expressed in arbitrary units (au; n ¼ 50
cells; three independent experiments, ∗∗∗P, 0.001). (E) Immunoblotting andquantification ofZO1 inPTcells fromCtnskidneys. Equal amounts of proteins (15 mg)
from7-day-oldprimarycultured cells (sixwells/sample)were loadedonSDS–PAGE, transferred to nitrocellulose andprobedwith anti-ZO1antibodies. Loadingwas
normalized forb-actin. The expression of ZO1 is decreased inCtns2/2 cells, compared with wild-type cells. Values are expressed as mean+SEM, ∗∗P , 0.01. (F)
Short-circuit current (Isc) and transepithelial resistance (Rt) measured simultaneously on 7-day-old monolayers of primary cultured PT cells (n ¼ 5) isolated from
20-week Ctns+/+ (white bar) and Ctns2/2 (black bar) mice. A strong reduction in Isc (5.4+0.76 versus 14.2+0.63 mA/cm
2) and Rt (26.2+2.3 versus 58.4+
2.7 V/cm2) is observed in Ctns2/2 versus Ctns+/+ cells. ∗∗P , 0.01; ∗∗∗P, 0.001.
Human Molecular Genetics, 2014, Vol. 23, No. 9 2275
primary cultured cells, lysed in lysis buffer containing protease
inhibitors (Complete MiniR, Roche Diagnostics, Belgium), fol-
lowed by sonication and centrifugation at 16 000 g for 1 min at
48C. Tissue, cell and urine samples were thawed on ice, normal-
ized for protein (20 mg/lane) or urinary creatinine levels, diluted
in Laemmli buffer and separated by sodium dodecyl sulphate–
polyacrylamide gel electrophoresis (SDS–PAGE) in reducing
conditions. After blotting onto nitrocellulose and blocking,
membranes were incubated overnight at 48C with primary anti-
body, washed, incubated with peroxidase-labeled secondary
antibody, and visualized with enhanced chemiluminescence
(ECL Pierce). For reprobing, the membranes were rinsed, incu-
bated for 30 min at 558C in a stripping buffer (62.5 mmol/l
Tris-HCl, 2% SDS, 100 mM - mercaptoethanol, pH 7.4), before
incubation with primary antibodies. Quantitative analysis was
performed by scanning the blots and measuring the relative
density of each band normalized to b-actin using NIH-Image
V1–57 software.
Immunofluorescence and confocal imaging
Mouse kidneys were snap-frozen in cryogenic Tissue-Tek OCT
compound (ElectronMicroscopy Sciences, Hatfield, USA). The
embedded tissue was sectioned at 6 mm with a Leica cryostat
(Leica, Heerbrugg, Switzerland). The sections were fixed with
4% paraformaldehyde, blocked with PBS containing 5% BSA,
and incubated for 1 h with primary antibodies. After three PBS
rinses, fluorophore-conjugated Alexa secondary antibodies
(Invitrogen)were applied for 30 min. Sectionswere subsequent-
ly mounted in Prolong Gold Anti-fade reagent (Invitrogen) and
then analysed under a Zeiss LSM510Meta Confocalmicroscope
(Carl Zeiss).
The cells were fixed for 10 min with 4% paraformaldehyde
(Sigma) in PBS, quenched with 50 mM NH4Cl and permeabi-
lized for 30 min in blocking buffer (0.1% (w/v) Triton X-100,
0.5% (w/v) BSA in PBS/Ca/Mg). The cells were incubated for
2 h with the primary antibody, washed three times in PBS, incu-
bated for 1 h with the secondary (Alexa labelled) antibody,
washed three times in PBS andwere finally taken onVectashield-
mounted coverslips. The samples were examined under a Zeiss
LSM 510 confocal laser-scanning microscope (Carl Zeiss)
equipped with ×63 oil-immersion objective. Image processing
was done with Adobe Photoshop C2 (Adobe Sysytem Inc., San
Jose, USA). To perform quantitative image analysis, 10–15 ran-
domly chosen fields that included 8–10 cells each were scanned,
using the same setting parameters (i.e. pinhole, laser power, offset
gain anddetector amplification) belowpixel saturation. Themean
intensity per cell was determined using the histogram function in
the Zeiss LSM 510 Software (version 3.2), and all of the pixel
values abovebackground levelswerequantified.All of the experi-
ments were repeated at least three times, and representative
images are shown. Quantification of number and the size of
LAMP1, LAMP2 and cathepsin D positive vesicles were per-
formed using the AnalySIS software (Soft Imaging Systems
GmbH, Muenster, Germany). Quantification was carried out on
at least 20 cells per condition from two to four independent experi-
ments.
Albumin endocytic uptake
The endocytosis assay was performed as described previously
(22). Monolayers of PT cells were washed with warm Hank’s
balanced salt solution (HBSS without phenol red with 10 mM
glucose, 5 mM glycine, 1 mM alanine, 15 mM HEPES, final pH
to 7.40 with TRIS base and osmolality to 325 mOsm/kg with
mannitol) after which they were incubated with 0.5 mg/ml
FITC- BSA for 15 min at 378C. After the incubation, primary
cultures were washed 6 times with cold HBSS (48C) and lysed
in lysis buffer (1 mM EDTA, 20 mM imidazole pH 7.2 and
250 mM sucrose). The fluorescence in the lysate was measured
in a single-beam fluorimeter (PerkinElmer, Santa Clara, USA)
at an excitation wavelength of 490+ 10 nm and emission
Table 2. Primers used for quantitative RT-PCR analyses
Gene product Forward primer (5′ –3′) Reverse primer (5′ –3′) PCR product (bp) Efficiency
Aqp1 GCTGTCATGTACATCATCGCCCAG AGGTCATTGCGGCCAAGTGAAT 107 0.99+0.02
Hspa1a ACCACCTACTCGGACAACCA CGAAGGTCACCTCGATCTGT 151 1.02+0.03
Car3 TGACCCTGGCTCTGCTAAGA AGCCCCAGTGAAGATGGAAT 178 1.01 0.02
Atp6v1e1 GGCGCTCAGCGATGCAGATGT CAAGGCGACCTTTCTCAATG 134 1.05+0.01
Sglt1 GTATGGTATGGTGGCCGATT AATATCCAGCCCAGCACAAC 157 0.99+0.02
DbpA AGGACGCGGAGAAGAAAGTT ACTTGCGTGGGTTGTTTTTC 153 0.96+0.04
Pcna TTGGAATCCCAGAACAGGAG ATTGCCAAGCTCTCCACTTG 155 1.00+0.03
Nrf2 CAGCCAGCTGACCTCCTTAG TCAATAGTCCCGTCCAGGAG 159 1.02+0.03
Ccnd1 AGCAGAAGTGCGAAGAGGAG CAAGGGAATGGTCTCCTTCA 151 1.01+0.03
Car2 CTTGAAGCACTGCATTCCAT CACGATCCAGGTCACACATT 154 1.02+0.03
Hmox1 AAGAGGCTAAGACCGCCTTC TCTCTGCAGGGGCAGTATCT 153 1.01+0.02
Sglt2 TTGGGCATCACCATGATTTA GCTCCCAGGTATTTGTCGAA 164 1.02+0.02
Cubn TCATTGGCCTCAGACATTCC CCCAGACCTTCACAAAGCTG 149 1.04+0.02
Lrp2 CAGTGGATTGGGTAGCAGGA GCTTGGGGTCAACAACGATA 150 1.01+0.03
Slc34a1 CATCACAGAGCCCTTCACAA TGGCCTCTACCCTGGACATA 161 0.98+0.03
Clcn5 TGGAGGAGCCAATCCCTGGTGT AGAAAGCATCGCTCACACTG 156 0.99+0.02
Ppiase CGTCTCCTTCGAGCTGTTTG CCACCCTGGCACATGAATC 139 1.02+0.02
Hprt1 ACATTGTGGCCCTCTGTGTG TTATGTCCCCCGTTGACTGA 162 0.99+0.01
Actb TGCCCATCTATGAGGGCTAC CCCGTTCAGTCAGGATCTTC 102 1.02+0.02
Gapdh TGCACCACCAACTGCTTAGC GGATGCAGGGATGGGGGAGA 176 1.04+0.03
Arbp CTTCATTGTGGGAGCAGACA TTCTCCAGAGCTGGGTTGTT 150 0.99+0.01
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wavelength at 520+ 10 nm. Fluorescence was normalized for
the amount of proteins in the primary cell cultures measured
using the bicinchoninic acid protein assay (Pierce, Aalst,
Belgium).
For live-cell imaging, confluent monolayers of mPTC were
incubated with 0.5 mg/ml FITC-conjugated BSA for 7 min at
378C and washed. Fluorescence was chased up to 45 min after
exposure of the cells to albumin. Cells were examined using
the Zeiss LSM510Meta Confocal microscope (Carl Zeiss,
Belgium).
Quantification of lysosome distribution
To score lysosome distribution, cells were categorized into
perinuclear-dominant lysosomal pattern (more than 50% of
LAMP1-positive vesicles localized in the perinuclear region)
and peripheral-dominant pattern (more than 50% of the vesicles
localized in the peripheral region). Quantification was based on
at least three independent experiments, each carried out in trip-
licate, and 100 cells were counted in each slide; the scorer was
blinded to treatment. The data are expressed as a proportion of
cells with predominantly (.50%) perinuclear lysosomes.
FRAP assay for cathepsin B activity
The lysosomal cathepsin B activity was measured in primary
cultures of PT cells using the membrane-permeable Magic
RedTM tracer coupled to the FRAP assay. The primary cells
were transferred to a physiological imaging buffer (NaCl
130 mM, KCl 5 mM, CaCl2 2.5 mM, MgCl2 2.5 mM, HEPES
25 mM) containing the Magic Red cathepsin B peptide (AbD
Serotec, Oxford, UK) added to the medium at 1:10 dilution
and incubatedat 378C.Live cell imaging andfluorescence recov-
ery analysis were done using LSM510 Zeiss confocal micro-
scope. To achieve photobleaching of individual Magic
Red-positive lysosomes, areas of interest were drawn around
selected spots, and movie acquisition was started. Sixty
seconds later, the spots were photobleached using 458, 488,
543, and 633 nm lasers with a 63× objective. Approximately
5 to 8 cells per field of view were bleached for a duration of
100 bleaching cycles according to the bleaching module
within LSM510 software (LSM 510 version 3.2). The recovery
of fluorescence was monitored over time (400 s) by scanning
the bleached area at the conventional (low) laser power to min-
imize photobleaching during sampling. To analyze the rate of re-
covery,we compared the fluorescence of the photobleached area
to that of an adjacent unbleached area of the same cell with
similar fluorescence intensity. For each time point, the fluores-
cence of the bleached areawas normalized to that of correspond-
ing control (unbleached) area to correct for possible drift of the
focal plane or photobleaching incurred during the low light sam-
pling.Quantification of fluorescencewas carried out usingVolo-
city software,with each data set having approximately 25 cells in
each condition analyzed, and each curve representing results
from 3 experiments. For each experimental FRAP curve, the
t1/2 valuewas calculated byfitting thedatawithBoltzmann func-
tion. The FRAP experiments were performed at 378C on Zeiss
LSM510 microscope equipped with Zeiss confocal scanning
laser using a x63 1.4 numerical aperture objective. The specifi-
city of tracer was verified by incubating primary cultured cells
with100 mMleupeptin (Calbiochem,MerckMillipore,Billerica,
USA) dissolved in dimethyl sulfoxide (DMSO) (vehicle) for 9 h
before exposing them to Magic Red (31).
Cystine measurement
The cystine assay was performed as previously described (32).
Briefly, dissected tissues or primary cultured cellswere homoge-
nized and lysed in the presence ofN-ethylmaleide to avoid inter-
ference from cysteine. Protein was determined on the pellet
using the Lowry method (32). After deproteinization, addition
of stable isotope d6cystine andbutylation, cystinewasmeasured
by liquid chromatography-tandem mass spectrometry using an
API 3000 mass spectrometer (Applied Biosystems).
Cell proliferation
Primary cultures of PT cells were incubated at Days 1, 3, 5, 6, 7
and 8 with BrdU (BrdU Cell Proliferation ELISA Kit, Abcam)
for 24 h at 378C. The cells were then fixed and permeabilized,
and DNA was denatured. The detector anti-BrdU monoclonal
antibody was added for 1 h and then washed away. A secondary
horseradish peroxidase-conjugated goat anti-mouse antibody
was added, which catalyzed the conversion of the chromogenic
substrate, and the coloured reaction productwas quantifiedusing
a Benchmark Plus microplate spectrophotometer (Bio-Rad).
Statistical analysis
Data were expressed as mean+SEM. Significance of differ-
ences was assessed by unpaired Student’s t test. P , 0.05 was
considered statistically significant.
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